The study sets out how gene expression that drives the formation of new blood vessels exhibits different patterns, cell by cell, in the brains of people with Alzheimer's disease.

Participants may be able to join this study if they have Down syndrome, are between 35 and 50 years old and have a study partner willing to attend all study visits.

The 5th Annual Vanderbilt Alzheimer's Disease Research Day, sponsored by the Vanderbilt Memory and Alzheimer's Center (VMAC), was held April 10 at Vanderbilt University School of Nursing.

Vanderbilt researchers are using artificial intelligence to search for existing drugs used for other problems that might help patients Alzheimer's Disease.

The Vanderbilt Center for Cognitive Medicine has been named an Alzheimer’s Clinical Trials Consortium Member Site.

A Vanderbilt study of genetic risks for cognitive impairment later in life uses data from 32,426 research participants ages 60 and older to elaborate these risks across sex and across the intersection of sex and race.

MRI brain scans at baseline for study participants 60 and older — who were free of clinical dementia at study entry — predicted a decline in independent function five years later.